Renata Lee

Person

Edison, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Humanized anti-CXCR5 antibodies, derivatives thereof and their uses
- Patent number 9,815,902
- Issue date Nov 14, 2017
- Sanofi
- Renata Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
- Patent number 9,243,067
- Issue date Jan 26, 2016
- Sanofi
- Renata Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
- Patent number 9,228,019
- Issue date Jan 5, 2016
- Sanofi
- Renata Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
- Patent number 9,175,087
- Issue date Nov 3, 2015
- Sanofi
- Renata Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
- Patent number 8,980,262
- Issue date Mar 17, 2015
- Sanofi
- Renata Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
- Patent number 8,647,622
- Issue date Feb 11, 2014
- Sanofi
- Renata Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their Uses
- Publication number 20220073629
- Publication date Mar 10, 2022
- SANOFI
- Renata Lee
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their Use
- Publication number 20180100019
- Publication date Apr 12, 2018
- Renata Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their Uses
- Publication number 20170044263
- Publication date Feb 16, 2017
- SANOFI
- Renata Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use
- Publication number 20130251714
- Publication date Sep 26, 2013
- SANOFI
- Renata Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use
- Publication number 20130246035
- Publication date Sep 19, 2013
- SANOFI
- Renata Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use
- Publication number 20130243783
- Publication date Sep 19, 2013
- SANOFI
- Renata Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use
- Publication number 20130243793
- Publication date Sep 19, 2013
- Renata Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use
- Publication number 20130236476
- Publication date Sep 12, 2013
- SANOFI
- Renata Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized anti-CXCR5 antibodies, derivatives thereof and their use
- Publication number 20110027266
- Publication date Feb 3, 2011
- Sanofi-Aventis
- Renata Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Person

Patents Grantslast 30 patents

Humanized anti-CXCR5 antibodies, derivatives thereof and their uses

Humanized anti-CXCR5 antibodies, derivatives thereof and their use

Humanized anti-CXCR5 antibodies, derivatives thereof and their use

Humanized anti-CXCR5 antibodies, derivatives thereof and their use

Humanized anti-CXCR5 antibodies, derivatives thereof and their use

Humanized anti-CXCR5 antibodies, derivatives thereof and their use

Patents Applicationslast 30 patents

Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their Uses

Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their Use

Humanized Anti-CXCR5 Antibodies, Derivatives Thereof and Their Uses

Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use

Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use

Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use

Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use

Humanized Anti-CXCR5 Antibodies, Derivatives Thereof And Their Use

Humanized anti-CXCR5 antibodies, derivatives thereof and their use